{{Rsnum
|rsid=9788333
|Gene=MIPEPP3
|Chromosome=13
|position=21301957
|Orientation=plus
|GMAF=0.2567
|Gene_s=MIPEPP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 33.3 | 52.4 | 14.3
| HCB | 47.6 | 42.9 | 9.5
| JPT | 48.9 | 37.8 | 13.3
| YRI | 83.9 | 16.1 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 47.6 | 42.9 | 9.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=4E-6
  |OR=28.65
  |ORtxt=[16.46-40.84] mg/dL decrease
  |OA=1
}}